Bill Sponsor
Senate Bill 1553
115th Congress(2017-2018)
Stopping Overdoses of Fentanyl Analogues Act
Introduced
Introduced
Introduced in Senate on Jul 13, 2017
Overview
Text
Introduced in Senate 
Jul 13, 2017
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in Senate(Jul 13, 2017)
Jul 13, 2017
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
S. 1553 (Introduced-in-Senate)


115th CONGRESS
1st Session
S. 1553


To amend the Controlled Substances Act to list fentanyl analogues as schedule I controlled substances.


IN THE SENATE OF THE UNITED STATES

July 13, 2017

Mr. Johnson introduced the following bill; which was read twice and referred to the Committee on the Judiciary


A BILL

To amend the Controlled Substances Act to list fentanyl analogues as schedule I controlled substances.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Stopping Overdoses of Fentanyl Analogues Act”.

SEC. 2. Fentanyl Analogues.

Section 202(c) of the Controlled Substances Act (21 U.S.C. 812) is amended—

(a) by adding at the end of subsection (b) of Schedule I the following:

“(23) Acetyl fentanyl 4-methylphenethyl.

“(24) Acrylfentanyl.

“(25) 4-fluorobutyrylfentanyl.

“(26) 4-fluoroisobutyryl fentanyl.

“(27) 3-furanyl fentanyl.

“(28) Isobutyryl fentanyl.

“(29) Meta-fluorofentanyl.

“(30) Methoxyacetyl fentanyl.

“(31) 4-methoxybutyrfentanyl.

“(32) Ocfentanil.

“(33) Ortho-fluorofentanyl.

“(34) Tetrahydrofuranyl fentanyl.

“(35) Valeryl fentanyl.”; and

(b) by adding at the end of Schedule I the following:

“(e) (1) Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of fentanyl analogues, or which contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.

“(2) In paragraph (1), the term ‘fentanyl analogues’ includes any compound structurally derived from fentanyl—

“(A) by replacement of the phenyl portion of the phenethyl group by any monocycle, whether or not further substituted in or on the monocycle;

“(B) by substitution in or on the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halo, haloalkyl, amino or nitro groups;

“(C) by substitution in or on the piperidine ring with alkyl, alkenyl, alkoxy, ester, ether, hydroxy, halo, haloalkyl, amino or nitro groups;

“(D) by replacement of the aniline ring with any aromatic monocycle whether or not further substituted in or on the aromatic monocycle; or

“(E) by replacement of the N-propionyl group by another acyl group.”.